Farde L, Suhara T, Halldin C, Nyback H, Nakashima Y, Swahn CG,
Karlsson P, Ginovart N, Bymaster FP, Shannon HE, Foged C,
Suziak PD, Sauerberg P (1996) PET study of the M1-agonists
[11C]xanomeline and [11C]butylthio-TZTP in monkey and man.
Dementia 7:187–195
Fisher A (1999) Muscarinic receptor agonists in Alzheimer's disease.
CNS Drugs 12:197–214
Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RLE, Carey JE, Wieland DM, Kuhl DE (1992) In vivo
muscarinic cholinergic receptor imaging in human brain with
[11C]scopolamine and positron emission tomography. J Cereb
Blood Flow Metab 12:147–154
Grieg NH, Pei X-F, Soncrant DK, Brossi A (1995) Phenserine and ring
C hetero-analogues: drug candidates for the treatment of Alzheimer's disease. Med Res Rev 15:3–31
Hosey MM, Pals-Rylaarsdam R, Lee KB, Roseberry AG, Benovic JL,
Gurevich VV, Bünemann M (1999) Molecular events associated
with the regulation of signaling by M muscarinic receptors. Life
2

Sci 64:363–368
Iversen LL, De Champlain J, Glowinsky J, Axelrod J (1967) Uptake,
storage, and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther 157:509–516
Kilbourn MR, Sherman PS, Snyder SE (1999) Simplified methods for
in vivo measurement of acetylcholinesterase activity in rodent
brain. Nucl Med Biol 26:543–550
Koenig JA, Edwardson JM (1996) Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type.
Mol Pharmacol 49:351–359
Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee
KS, Kuhl DE (1994) [11C]Tropanyl benzilate binding to muscarinic cholinergic receptors: methodology and kinetic modeling al- ternatives. J Cereb Blood Flow Metab 14:85–99
Krudewig R, Langer B, Vögler O, Markschies N, Erl M, Jakobs KH,
van Koppen CJ (2000) Distinct internalization of M muscarinic
2

acetylcholine receptors confers selective and long-lasting desensitization of signaling to phospholipase C. J Neurochem 74:1721–
1730
Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL,
Frey KA, Kilbourn MR (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52:691–699
Laruelle M (2000) Imaging synaptic neurotransmission with in vivo
binding competition techniques: a critical review. J Cereb Blood
Flow Metab 20:423–451
Lee J, Paik CH, Kiesewetter DO, Park SG, Eckelman WC (1995)
Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2,
and M3 muscarinic receptor subtypes in brain. Nucl Med Biol
22:773–781
